Drugs / ENP-501
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT07117669 | Dec 2025 → Nov 2028 expected | food allergy | N-Fold, LLC | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ENP-501 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07117669 ↗ |
| Route | Other | “buccal administrations of ENP-501” NCT07117669 ↗ |